ELEKTA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 75 SEK | -1.12% |
|
-4.70% | -8.89% |
| Mar. 06 | ELEKTA : Elekta’s attractiveness reinforced |  |
| Mar. 01 | Elekta AB Announces Resignation of Kelly Londy, Member of the Board | CI |
| Sales 2024 * | 18.22B 1.67B | Sales 2025 * | 19.23B 1.76B | Capitalization | 28.98B 2.66B |
|---|---|---|---|---|---|
| Net income 2024 * | 1.48B 136M | Net income 2025 * | 1.82B 167M | EV / Sales 2024 * | 1.76 x |
| Net Debt 2024 * | 3.02B 277M | Net Debt 2025 * | 2.63B 241M | EV / Sales 2025 * | 1.64 x |
| P/E ratio 2024 * |
19.6
x | P/E ratio 2025 * |
15.9
x | Employees | 4,584 |
| Yield 2024 * |
3.32% | Yield 2025 * |
3.74% | Free-Float | 89.83% |
More Fundamentals
* Assessed data
More news
Latest transcript on Elekta AB
More recommendations
More press releases
More news
| 1 day | -1.30% | ||
| 1 week | -5.78% | ||
| Current month | -6.01% | ||
| 1 month | -4.88% | ||
| 3 months | -4.23% | ||
| 6 months | -2.56% | ||
| Current year | -7.86% |
1 week
75.00
79.40
1 month
75.0084.65
Current year
70.0085.86
1 year
70.0090.42
3 years
53.24132.35
5 years
53.24145.45
10 years
50.25145.45
| Managers | Title | Age | Since |
|---|---|---|---|
Laurent Leksell
FOU | Founder | 72 | 71-12-31 |
Gustaf Salford
CEO | Chief Executive Officer | 47 | 08-12-31 |
Tobias Hägglöv
DFI | Director of Finance/CFO | 46 | 22-01-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Laurent Leksell
FOU | Founder | 72 | 71-12-31 |
| Director/Board Member | 67 | 10-06-29 | |
| Director/Board Member | 67 | 04-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.97% | 152 M€ | -0.15% | - | |
| 0.35% | 233 M€ | +6.99% | ||
| 0.04% | 773 M€ | 0.00% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 75 | -1.12% | 805 814 |
| 24-04-17 | 75.85 | -1.30% | 832,966 |
| 24-04-16 | 76.85 | -1.28% | 718,616 |
| 24-04-15 | 77.85 | +0.91% | 790,674 |
| 24-04-12 | 77.15 | -1.97% | 1,123,765 |
Delayed Quote Nasdaq Stockholm, April 17, 2024 at 11:29 am EDT
More quotes
Elekta publ AB is a Sweden-based human care company that develops and sells clinical solutions for the treatment of cancer and brain disorder. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. The Company has four product areas: Elekta Neuroscience, which develops solutions for the diagnosis and treatment of neurological diseases; Elekta Oncology, which creates clinical solutions for radiation therapy, such as linear accelerators, integrated imaging systems and clinical solutions for patient positioning and immobilization; Elekta Brachytherapy, which is engaged in the treatment of cancer through internal radiation, and Elekta Software, which develops software solutions for patient information, workflow management and treatment planning in oncology. The Company owns the service business of Asesores Electronicos Especializados SA de CV (AEESA).
Calendar
2024-06-04
- Q4 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A
Sell
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
75.85
SEK
Average target price
83.42
SEK
Spread / Average Target
+9.98%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -7.86% | 2.64B | |
| +3.10% | 209B | |
| +3.48% | 177B | |
| +10.91% | 133B | |
| +17.56% | 99.89B | |
| -0.99% | 61.83B | |
| +14.41% | 52.51B | |
| -6.21% | 45.54B | |
| -3.22% | 39.43B | |
| +10.18% | 38.87B |
- Stock Market
- Equities
- EKTA B Stock
